Copyright: ©Author(s) 2026.
World J Psychiatry. Jul 19, 2026; 16(7): 116727
Published online Jul 19, 2026. doi: 10.5498/wjp.116727
Published online Jul 19, 2026. doi: 10.5498/wjp.116727
Table 1 Baseline characteristics comparison, n (%)/mean ± SD
| Variable | CSGB group (n = 65) | Control group (n = 70) | Statistics | P value |
| Age (year) | 58.3 ± 8.7 | 59.1 ± 9.2 | t = 0.521 | 0.603 |
| Gender (male) | 37 (56.9) | 41 (58.6) | χ2 = 0.041 | 0.840 |
| BMI (kg/m2) | 23.8 ± 3.2 | 24.1 ± 3.5 | t = 0.521 | 0.603 |
| Smoking history (yes) | 29 (44.6) | 33 (47.1) | χ2 = 0.092 | 0.762 |
| Comorbidities (yes) | 25 (38.5) | 28 (40.0) | χ2 = 0.035 | 0.851 |
| Tumor stage (I-II) | 53 (81.5) | 55 (78.6) | χ2 = 0.180 | 0.671 |
| Surgical method (lobectomy) | 50 (76.9) | 54 (77.1) | χ2 = 0.002 | 0.964 |
| Operative time (minute) | 142.5 ± 28.3 | 145.2 ± 30.1 | t = 0.541 | 0.590 |
| Intraoperative blood loss (mL) | 92.4 ± 21.7 | 95.3 ± 23.5 | t = 0.741 | 0.460 |
Table 2 Emotional score changes, mean ± SD
| Scale | Time point | CSGB group (n = 65) | Control group (n = 70) | Statistics | P value |
| SAS | Preoperative | 38.4 ± 5.2 | 38.9 ± 5.5 | t = 0.541 | 0.590 |
| Postoperative day 1 | 46.1 ± 6.0 | 47.3 ± 6.4 | t = 1.130 | 0.261 | |
| Postoperative day 3 | 42.8 ± 6.3 | 49.2 ± 7.1 | t = 5.620 | < 0.01 | |
| Postoperative day 7 | 38.2 ± 5.4 | 45.3 ± 6.5 | t = 6.930 | < 0.01 | |
| SDS | Preoperative | 37.8 ± 4.9 | 38.2 ± 5.1 | t = 0.471 | 0.639 |
| Postoperative day 1 | 45.3 ± 5.7 | 46.5 ± 6.0 | t = 1.210 | 0.229 | |
| Postoperative day 3 | 41.5 ± 5.9 | 48.7 ± 6.8 | t = 6.480 | < 0.01 | |
| Postoperative day 7 | 37.1 ± 5.2 | 44.8 ± 6.1 | t = 7.840 | < 0.01 |
Table 3 Comparison of Visual Analog Scale scores at different postoperative time points, mean ± SD
| State | Time point | CSGB group (n = 65) | Control group (n = 70) | Statistics | P value |
| Resting VAS | Postoperative day 1 | 3.2 ± 0.8 | 4.1 ± 0.9 | t = 6.12 | < 0.05 |
| Postoperative day 3 | 2.1 ± 0.6 | 3.2 ± 0.8 | t = 8.93 | < 0.05 | |
| Postoperative day 7 | 1.3 ± 0.4 | 2.3 ± 0.6 | t = 11.34 | < 0.05 | |
| Movement VAS | Postoperative day 1 | 4.3 ± 1.0 | 5.4 ± 1.2 | t = 5.71 | < 0.05 |
| Postoperative day 3 | 3.0 ± 0.7 | 4.2 ± 0.9 | t = 8.54 | < 0.05 | |
| Postoperative day 7 | 2.1 ± 0.5 | 3.4 ± 0.8 | t = 11.07 | < 0.05 |
Table 4 Sleep quality improvement, mean ± SD
| Indicator | Time point | CSGB group (n = 65) | Control group (n = 70) | Statistics | P value |
| PSQI total score | Preoperative | 5.1 ± 1.2 | 5.0 ± 1.3 | t = 0.46 | 0.646 |
| Postoperative day 7 | 6.8 ± 1.5 | 9.2 ± 1.8 | t = 8.52 | < 0.05 | |
| Subjective sleep quality | Postoperative day 7 | 1.1 ± 0.3 | 1.6 ± 0.4 | t = 8.06 | < 0.05 |
| Sleep latency | Postoperative day 7 | 1.0 ± 0.2 | 1.5 ± 0.4 | t = 8.96 | < 0.05 |
| Sleep efficiency | Postoperative day 7 | 0.9 ± 0.2 | 1.4 ± 0.3 | t = 10.81 | < 0.05 |
| Sleep disturbances | Postoperative day 7 | 1.2 ± 0.3 | 1.7 ± 0.4 | t = 7.96 | < 0.05 |
| Daytime dysfunction | Postoperative day 7 | 1.1 ± 0.3 | 1.6 ± 0.4 | t = 8.06 | < 0.05 |
| PSQI ≥ 7, n (%) | Postoperative day 7 | 21 (32.3) | 43 (61.4) | χ2 = 11.22 | < 0.01 |
Table 5 Accelerated recovery progress, mean ± SD
| Indicator | CSGB group (n = 65) | Control group (n = 70) | Statistics | P value |
| Time to first ambulation (hour) | 18.5 ± 4.2 | 26.3 ± 5.1 | t = 9.51 | < 0.05 |
| Chest tube removal time (day) | 3.2 ± 0.8 | 4.1 ± 0.9 | t = 6.07 | < 0.05 |
| Postoperative hospital stay (day) | 6.8 ± 1.3 | 8.5 ± 1.6 | t = 6.71 | < 0.05 |
| Postoperative day 3 walking distance (m) | 82.5 ± 15.3 | 63.2 ± 12.7 | t = 7.92 | < 0.05 |
| Time to first flatus (hour) | 28.4 ± 5.6 | 34.7 ± 6.2 | t = 6.27 | < 0.05 |
| Time to first defecation (hour) | 48.3 ± 8.1 | 56.9 ± 9.4 | t = 5.67 | < 0.05 |
| Postoperative day 3 ADL score (Barthel Index) | 85.2 ± 8.7 | 76.8 ± 10.3 | t = 5.21 | < 0.05 |
| Postoperative day 3 serum albumin (g/L) | 38.6 ± 3.4 | 35.9 ± 3.8 | t = 4.41 | < 0.05 |
Table 6 Reduced complications, n (%)
| Complication | CSGB group (n = 65) | Control group (n = 70) | χ2 value | P value |
| Nausea and vomiting | 9 (13.8) | 20 (28.6) | 4.57 | < 0.05 |
| Arrhythmias | 3 (4.6) | 9 (12.9) | 3.89 | < 0.05 |
| Pulmonary infection | 4 (6.2) | 11 (15.7) | 4.23 | < 0.05 |
| Subcutaneous emphysema | 5 (7.7) | 7 (10.0) | 0.29 | 0.592 |
| Atelectasis | 2 (3.1) | 4 (5.7) | 0.64 | 0.424 |
| Pleural effusion | 3 (4.6) | 8 (11.4) | 3.32 | < 0.05 |
| Incisional infection | 1 (1.5) | 6 (8.6) | 3.91 | < 0.05 |
| Deep vein thrombosis | 0 (0.0) | 4 (5.7) | 4.21 | < 0.05 |
| Urinary retention | 2 (3.1) | 7 (10.0) | 3.12 | < 0.05 |
| Total complications | 16 (24.6) | 30 (42.9) | 5.60 | < 0.05 |
- Citation: Liu X, Jing W, Sun XJ, Zhang L, Wang YM. Clinical mechanisms of continuous stellate ganglion block in improving postoperative anxiety and depression after thoracoscopic lung cancer surgery. World J Psychiatry 2026; 16(7): 116727
- URL: https://www.wjgnet.com/2220-3206/full/v16/i7/116727.htm
- DOI: https://dx.doi.org/10.5498/wjp.116727